UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: May 17, 2022
Accession Number: 0001193125-22-066056
Submission Type: POS AM
CIK: 0001662774
Company Name: Cortexyme, Inc.
File Number: 333-238851
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Quince Therapeutics Charts.
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Quince Therapeutics Charts.